No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
331 |
4. Check minimum number of eventsNone |
331 |
5. Include endpointsNone |
331 |
6. Filter based on genotype QC (FinnGen only) |
312 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEQULEAE_OF_INFECTIONS_AND_PARASITES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Sequelae of poliomyelitis
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 312 | 145 | 167 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.08 |
| Median age at first event (years) | 61.20 | 59.82 | 62.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 331
- Matched controls
- 3310
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B91
ICD-10 Finland
Sequelae of poliomyelitis
+∞
307.7
295
*
1380A
ICD-9 Finland
Late effects of acute poliomyelitis[SEQUELAE POLIOMYELITIDIS]
+∞
79.4
73
*
N70
ICPC
Poliomyelitis
+∞
68.1
63
*
04499
ICD-8 Finland
Late effects of actue poliomyelitis
+∞
56.9
53
*
L28
ICPC
Limited function/disability (L)
3.5
25.9
124
478
SPAT1229
SPAT
Assessment of need for aid
4.3
21.9
65
178
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.0
17.8
28
43
A28
ICPC
Limited function/disability NOS
2.6
13.9
110
534
M89.6
ICD-10 Finland
Osteopathy after poliomyelitis
+∞
12.6
12
*
N18
ICPC
Paralysis/weakness
6.3
12.3
21
35
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
10.0
79
376
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
9.0
77
379
Z02.7
ICD-10 Finland
Issue of medical certificate
3.3
8.7
34
111
S72.4
ICD-10 Finland
Fracture of lower end of femur
16.8
8.6
13
8
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
8.4
55
239
R5110, ,
SPAT
3.0
8.3
38
136
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
8.1
23
60
M41.9
ICD-10 Finland
Scoliosis, unspecified
10.4
7.6
14
14
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.7
7.3
17
38
N03AE01
ATC
clonazepam; systemic
3.3
6.9
27
88
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.0
6.7
31
112
XG466
NOMESCO Finland
Sleep oxymetry
4.0
6.3
18
47
A99
ICPC
Disease/condition unspecnature/site
2.6
6.2
38
159
L99
ICPC
Musculoskeletal disease other
6.2
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
150
1075
1.72
5.49
2.4
2.2
81.14
79.00
nmol/l
0.38
130
933
169
1266
1.68
5.14
5.3
4.3
33.45
34.83
g/l
2.17
154
1173
170
1308
1.62
4.43
6.4
5.7
1.21
1.21
mmol/l
0.08
155
1181
184
1445
1.62
4.39
8.2
6.3
1.22
1.21
mmol/l
0.56
159
1228
58
343
1.84
3.97
4.5
4.0
17.30
49.69
ug/l
0.62
47
296
103
720
1.63
3.87
1.6
1.6
18.91
20.55
nmol/l
0.59
83
595
156
1217
1.53
3.58
2.2
2.1
90.39
91.80
pmol/l
0.13
77
614
8
13
6.28
3.52
1.0
1.0
—
—
—
0
0
43
258
1.77
2.81
1.7
2.0
0.22
0.21
g/l
0.54
38
236
234
2051
1.48
2.67
7.8
7.7
80.29
79.61
u/l
0.07
216
1913
57
379
1.61
2.56
6.2
6.2
2.08
1.17
mmol/l
1.15
50
300
41
255
1.69
2.38
3.1
2.2
33.69
33.19
u/l
0.03
35
209
80
584
1.49
2.37
3.7
4.0
167.85
228.79
ng/l
0.21
71
511
56
381
1.57
2.29
6.4
6.1
11.75
11.83
kpa
0.04
51
364
56
381
1.57
2.29
6.3
6.1
5.34
5.05
kpa
1.56
51
364
172
1457
1.38
2.18
11.9
17.4
1.33
1.33
inr
0.03
47
401
80
598
1.45
2.09
4.3
3.1
2.47
2.46
mmol/l
0.43
69
527
120
971
1.37
1.98
4.4
3.2
2.34
2.35
mmol/l
0.24
104
844
29
175
1.72
1.90
2.4
3.5
1.97
2.15
mmol/l
0.15
24
133
0
52
0.00
1.90
0.0
1.5
—
—
—
0
0
21
119
1.82
1.70
5.4
3.5
26.95
41.92
u/ml
0.61
21
114
64
477
1.42
1.69
3.9
3.1
2.97
1.94
e6/l
0.27
39
269
80
623
1.37
1.64
2.0
1.7
1188.59
1188.99
nmol/l
0.00
63
470
93
743
1.35
1.62
2.8
2.1
2.82
3.25
mg/l
1.08
82
638
40
274
1.52
1.61
4.2
3.4
2.82
2.01
mmol/l
0.92
35
222
166
1444
1.30
1.58
6.7
6.3
10.51
11.80
umol/l
1.21
157
1361
0
42
0.00
1.53
0.0
1.4
—
—
—
0
0
57
424
1.42
1.53
2.4
2.2
2.22
2.26
g/l
0.20
49
389
267
2491
1.37
1.47
20.0
17.1
28.86
26.47
mg/l
0.56
226
2031
12
60
2.04
1.40
1.1
1.5
—
—
—
0
0
12
60
2.04
1.40
1.1
1.5
—
—
—
0
0
0
38
0.00
1.35
0.0
1.6
—
—
—
0
0
0
39
0.00
1.34
0.0
1.6
—
—
—
0
0
32
218
1.52
1.34
4.0
3.2
109.46
84.34
ng/l
0.55
27
191
60
462
1.36
1.32
2.6
2.2
11.57
12.05
umol/l
0.21
53
426
5
18
2.80
1.29
1.2
1.1
—
—
—
0
0
100
837
1.28
1.23
2.5
2.3
56.93
63.08
u/l
0.47
89
779
181
1625
1.25
1.22
5.7
4.7
7.07
6.88
mmol/l
0.51
169
1527
8
37
2.19
1.22
1.0
1.4
—
—
—
0
0
64
506
1.33
1.19
2.1
1.8
—
—
—
0
0
8
38
2.13
1.19
1.0
1.3
—
—
—
0
0
0
36
0.00
1.14
0.0
1.6
—
—
—
0
0
5
21
2.40
1.09
1.4
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
97
1.68
1.08
1.9
2.1
0.39
0.32
u/ml
—
9
50
31
221
1.44
1.07
1.9
1.6
—
—
—
0
0
118
1024
1.24
1.05
3.0
2.6
129.13
141.82
ug/l
0.28
109
918
134
1179
1.23
1.05
5.8
5.8
25.49
25.74
%
0.09
123
1092
7
34
2.08
1.03
1.0
1.2
—
—
—
0
0
7
34
2.08
1.03
1.0
1.0
—
—
—
0
0
11
61
1.83
0.99
1.2
1.1
554.00
499.13
mg/l
0.30
11
56
45
348
1.34
0.99
2.1
1.8
—
—
—
0
0
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
62
503
1.29
0.97
3.7
2.9
0.73
1.08
e6/l
0.69
38
291
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
81
685
1.24
0.91
1.6
1.6
1.28
1.29
mmol/l
0.03
72
553
51
409
1.29
0.88
2.6
2.2
20.49
21.10
%
0.14
41
349
6
30
2.02
0.87
2.0
1.3
—
—
—
0
0
17
112
1.55
0.86
2.4
2.0
372.60
348.40
ug/l
0.05
17
103
130
1163
1.19
0.82
5.6
5.5
58.65
58.60
%
0.01
118
1082
91
788
1.21
0.81
3.1
3.3
37.79
32.53
u/l
0.60
81
751
119
1059
1.19
0.80
4.2
3.3
—
—
—
0
0
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
0
26
0.00
0.78
0.0
3.9
—
—
—
0
0
154
1405
1.18
0.77
3.2
3.3
48.93
54.32
u/l
0.38
139
1273
15
99
1.54
0.77
1.3
1.3
—
—
—
0
0
58
482
1.25
0.76
1.3
1.2
14.20
1.00
u/ml
1.01
11
128
9
53
1.72
0.76
1.8
1.1
—
—
—
0
0
26
343
0.74
0.75
1.1
1.3
1.22
17.84
u/ml
—
6
118
16
108
1.51
0.75
2.9
4.2
25.43
25.52
mmol/l
0.05
16
101
7
39
1.81
0.73
3.1
3.0
58.29
60.18
%
—
7
39
277
2667
1.24
0.71
23.4
20.1
139.03
139.64
mmol/l
2.39
270
2589
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
277
2670
1.23
0.68
23.8
20.2
3.95
4.01
mmol/l
2.52
269
2591
43
351
1.26
0.67
1.9
1.9
—
—
—
0
0
27
347
0.76
0.66
9.3
7.7
—
—
—
0
0
10
62
1.63
0.66
1.2
1.3
—
—
—
0
0
203
1912
1.16
0.63
4.0
4.4
16.21
14.37
mm/h
0.88
190
1728
8
49
1.65
0.62
1.5
1.2
—
—
—
0
0
137
1257
1.15
0.61
2.4
2.7
—
—
—
0
0
8
52
1.55
0.60
1.6
1.3
—
—
—
0
0
24
184
1.33
0.59
1.6
1.7
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
92
822
1.17
0.58
4.0
3.3
0.28
0.67
e6/l
1.41
71
622
280
2713
1.21
0.58
27.4
25.0
253.04
240.02
e9/l
2.33
266
2631
223
2123
1.15
0.57
24.2
20.4
14.91
15.51
%
1.11
217
2085
8
54
1.49
0.57
1.8
1.4
—
—
—
0
0
280
2714
1.21
0.57
27.8
25.0
4.34
4.40
e12/l
1.13
265
2616
280
2714
1.21
0.57
28.1
25.1
38.54
39.41
%
1.30
246
2499
280
2714
1.21
0.57
27.9
25.2
129.73
133.03
g/l
2.96
272
2661
13
183
0.70
0.57
1.5
1.4
—
—
—
0
0
274
2652
1.19
0.56
23.5
20.5
72.67
82.67
umol/l
4.40
274
2652
137
1267
1.14
0.53
3.6
4.3
0.00
0.00
estimate
0.50
25
264
137
1267
1.14
0.53
4.8
5.8
0.00
0.00
estimate
-0.00
23
241
10
66
1.53
0.53
2.3
1.5
—
—
—
0
0
6
98
0.61
0.53
1.0
1.3
—
—
—
0
0
272
2636
1.18
0.52
11.4
11.3
26.18
24.16
u/l
0.88
260
2521
36
301
1.22
0.48
3.6
3.8
—
—
—
0
0
7
48
1.47
0.47
1.0
1.8
—
—
—
0
0
72
643
1.15
0.46
1.9
1.8
442.11
429.87
pmol/l
0.15
57
521
63
557
1.16
0.46
1.4
1.7
1.03
1.47
mg/l
1.34
51
435
12
86
1.41
0.45
1.5
1.7
—
132.00
—
0
5
62
695
0.87
0.43
2.7
2.9
7315.17
7839.08
umol/l
0.03
52
579
137
1281
1.12
0.43
3.6
4.4
0.00
0.00
estimate
-0.00
24
230
5
32
1.57
0.42
1.2
1.1
152.00
358.00
u/ml
—
5
14
13
96
1.37
0.42
3.8
4.7
—
2.50
—
0
13
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
28
237
1.20
0.35
1.3
1.3
—
—
—
0
0
14
111
1.27
0.30
2.1
1.7
—
—
—
0
0
32
363
0.87
0.28
4.8
4.7
27.47
32.00
%
2.09
17
233
177
1835
0.92
0.28
3.8
3.8
15.51
15.12
pmol/l
1.20
157
1608
72
670
1.10
0.25
2.5
2.4
—
—
—
0
0
20
170
1.19
0.25
1.9
2.0
14.03
13.35
nmol/l
0.17
15
148
123
1172
1.08
0.25
3.6
4.3
69.63
45.44
ng/l
0.45
93
927
151
1451
1.07
0.24
9.3
9.1
4.28
4.27
e9/l
0.01
124
1269
94
887
1.08
0.24
2.5
2.1
449.70
248.83
u/l
0.34
86
823
98
927
1.08
0.24
4.5
3.7
17.77
9.74
mg/mmol
0.42
62
584
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
94
988
0.93
0.20
4.2
4.7
—
—
—
0
0
244
2393
1.07
0.20
6.4
6.6
40.37
41.23
mmol/mol
0.68
215
2194
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
6.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
9
114
0.78
0.20
1.7
2.7
4.34
4.34
pmol/l
—
9
101
116
1114
1.06
0.18
2.7
2.2
—
—
—
0
0
241
2367
1.07
0.18
20.5
16.3
81.05
72.40
ml/min/173m2
6.82
191
1946
227
2312
0.94
0.17
3.9
4.3
1.28
1.24
mmol/l
0.39
201
2049
5
67
0.74
0.17
1.2
1.6
—
—
—
0
0
60
566
1.07
0.16
4.1
4.8
1.02
1.02
kg/l
0.33
12
86
6
79
0.76
0.15
1.0
1.2
—
—
—
0
0
6
80
0.75
0.15
1.0
1.2
—
—
—
0
0
14
122
1.15
0.14
2.2
1.8
—
—
—
0
0
9
108
0.83
0.13
1.7
3.4
—
—
—
0
0
106
1026
1.05
0.13
2.3
3.1
1248.69
1801.45
ng/l
0.81
87
889
11
95
1.16
0.12
1.2
1.0
—
—
—
0
0
19
209
0.90
0.11
4.2
3.1
68.67
58.02
ml/min/173m2
—
9
85
86
890
0.95
0.11
3.7
4.6
25.27
21.49
%
1.29
35
473
7
65
1.08
0.08
1.3
1.5
—
—
—
0
0
7
68
1.03
0.08
1.1
1.3
—
—
—
0
0
7
80
0.87
0.07
1.3
1.2
—
—
—
0
0
8
91
0.88
0.07
2.4
2.5
0.00
0.00
g/l
—
8
84
8
90
0.89
0.07
2.4
2.5
0.00
0.00
g/l
—
8
84
108
1101
0.97
0.06
4.9
5.3
4.83
3.00
ug/l
0.33
93
969
23
243
0.94
0.06
3.0
3.9
1.24
1.22
mmol/l
1.22
18
215
247
2482
0.98
0.03
5.0
5.1
6.14
6.13
mmol/l
0.00
219
2212
238
2391
0.98
0.02
4.5
4.8
1.45
1.46
mmol/l
0.13
212
2133
16
152
1.06
0.02
1.9
2.6
1.32
1.12
%
0.48
16
152
37
361
1.03
0.02
1.1
1.3
13.20
46.37
iu/ml
—
10
124
249
2498
0.99
0.01
5.1
5.5
2.63
2.56
mmol/l
0.59
221
2228
13
132
0.98
0.00
1.5
1.4
—
60.41
—
0
11
15
148
1.01
0.00
2.0
2.5
0.72
0.67
%
0.18
15
148
230
2298
1.00
0.00
4.7
4.6
1.85
2.03
mu/l
1.03
202
2019
10
103
0.97
0.00
2.2
2.5
1.68
0.87
g/l
—
10
92
63
633
0.99
0.00
2.8
3.3
1.08
0.80
ug/l
0.99
42
458
241
2414
0.99
0.00
4.5
4.8
4.46
4.44
mmol/l
0.12
216
2173
13
126
1.03
0.00
1.9
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
1064.25
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
71
710
1.00
-0.00
4.3
4.5
0.00
0.00
estimate
-0.00
21
230
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
2.2
2.4
0.00
0.00
g/l
—
9
88
7
69
1.01
-0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
108.22
—
0
9
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1363.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.4
—
—
—
0
0
23
230
1.00
-0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.2
—
2.58
—
0
9
7
78
0.90
-0.00
1.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
-0.00
0.0
3.7
—
131.17
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_SEQULAE_POLIO_WIDE – Sequelae of poliomyelitis
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).